Details of the Drug Formulaction

General Information of Drug Formulation (ID: F22726)

• Formulation Name: Zafirlukast 20 mg tablet
• Company: AstraZeneca; Par Pharmaceutical

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Zafirlukast	(DMHNQOG)	Asthma	CA23	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carmellose sodium	(E00625)	Not Available	Disintegrant
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent